Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis

Figure 1

Flow schematic depicting inclusion and exclusion criteria for selection of studies. AX: predocetaxel abiraterone; EX: predocetaxel enzalutamide; DA: postdocetaxel abiraterone; DE: postdocetaxel enzalutamide; OS: overall survival; PFS: radiographic progression-free survival.